AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2022
Jul 29, 2022
32559_dirs_2022-07-28_1a2235e3-3b09-4a82-bad3-500b2e4da7c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2022-07-26
Reporting Person: Tripuraneni Radhika (N/A)